BOULDER, Colo., Aug. 12, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today reported results for the fourth quarter and full year of its fiscal year ending June 30, 2014. Ron Squarer, Chief Executive Officer of Array, noted, "The Array ... ...

42 people liked this